Signal transduction via platelet-derived growth factor receptors

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1378, Issue 1, 1998, Pages

  Heldin, Carl Henrik ^a   Östman, Arne ^a   Rönnstrand, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antagonist; Cell growth; Cell migration; Cell transformation; Kinase; Platelet derived growth factor; Receptor; Signal transduction

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE;

APOPTOSIS; AUTOPHOSPHORYLATION; CELL GROWTH; CELL MIGRATION; CELL TRANSFORMATION; DIMERIZATION; HUMAN; LIGAND BINDING; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

CELL DIVISION; CELL MOVEMENT; DIMERIZATION; FEEDBACK; INTEGRINS; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0032547385     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(98)00015-8     Document Type: Review

References (369)

1. E.W. Raines, D.F. Bowen-Pope, R. Ross, Platelet-derived growth factor, in: M.B. Sporn, A.B. Roberts (Eds.), Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, Vol. 95, Part I, Springer, Heidelberg, 1990, pp. 173-262.
2. C.-H. Heldin, B. Westermark, Role of platelet-derived growth factor in vivo, in: R.A.F. Clark (Ed.), The Molecular and Cellular Biology of Wound Repair, 2nd edn., Plenum Press, New York, 1996, pp. 249-273.
3. Levéen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1994;1875-1887.
4. Soriano P. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev. 8:1994;1888-1896.
5. Lindahl P., Johansson B.R., Levéen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 277:1997;242-245.
6. Boström H., Willetts K., Pekny M., Levéen P., Lindahl P., Hedstrand H., Pekna M., Hellström M., Gebre-Medhin S., Schalling M., Nilsson M., Kurland S., Törnell J., Heath J.K., Betsholtz C. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 85:1996;863-873.
7. Soriano P. The PDGFα receptor is required for neural crest cell development and for normal patterning of the somites. Development. 124:1997;2691-2700.
8. Robson M.C., Phillips L.G., Thomason A., Robson L.E., Pierce G.F. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet. 339:1992;23-25.
9. Rodt S.Å., Åhlén K., Berg A., Rubin K., Reed R.K. A novel physiological function for platelet-derived growth factor-BB in rat dermis. J. Physiol. (Lond.). 495:1996;193-200.
10. B.C. Berk, R.W. Alexander, T.A. Brock, M.A. Gimbrone Jr., R.C. Webb, Vasocontstriction: a new activity for platelet-derived growth factor, 232 (1986) 87-90.
11. Sachinidis A., Locher R., Hoppe J., Vetter W. 90)T. The platelet-derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms. FEBS Lett. 272:1990;95-98.
12. Cunningham L.D., Brecher P., Cohen R.A. Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta. J. Clin. Invest. 89:1992;878-882.
13. Bryckaert M.C., Rendu F., Tobelem G., Wasteson Å. Collagen-induced binding to human platelets of platelet-derived growth factor leading to inhibition of P43 and P20 phosphorylation. J. Biol. Chem. 264:1989;4336-4341.
14. Vassbotn F.S., Havnen O.K., Heldin C.-H., Holmsen H. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor α-receptor. J. Biol. Chem. 269:1994;13874-13879.
15. Eriksson A., Siegbahn A., Westermark B., Heldin C.-H., Claesson-Welsh L. PDGF α- and β-receptors activate unique and common signal transduction pathways. EMBO J. 11:1992;543-550.
16. Siegbahn A., Hammacher A., Westermark B., Heldin C.-H. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J. Clin. Invest. 85:1990;916-920.
17. Koyama H., Nishizawa Y., Hosoi M., Fukumoto S., Kogawa K., Shioi A., Morii H. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I - Possible involvement of cyclin-dependent kinase 2. Circ. Res. 79:1996;757-764.
18. Yokote K., Mori S., Siegbahn A., Rönnstrand L., Wernstedt C., Heldin C.-H., Claesson-Welsh L. Structural determinants in the platelet-derived growth factor α-receptor implicated in modulation of chemotaxis. J. Biol. Chem. 271:1996;5101-5111.
19. Osornio-Vargas A.R., Lindroos P.M., Coin P.G., Badgett A., Hernandez-Rodriguez N.A., Bonner J.C. Maximal PDGF-induced lung fibroblast chemotaxis requires PDGF receptor-α Am. J. Physiol./Lung Cell. Mol. Physiol. 271/15:1996;L93-L99.
20. Shure D., Senior R.M., Griffin G.L., Deuel T.F. PDGF AA homodimers are potent chemoattractants for fibroblasts and neutrophils, and for monocytes activated by lymphocytes or cytokines. Biochem. Biophys. Res. Commun. 186:1992;1510-1514.
21. Hosang M., Rouge M., Wipf B., Eggimann B., Kaufmann F., Hunziker W. Both homodimeric isoforms of PDGF (AA and BB) have mitogenic and chemotactic activity and stimulate phosphoinositol turnover. J. Cell. Physiol. 140:1989;558-564.
22. Yu J.-C., Heidaran M.A., Pierce J.H., Gutkind J.S., Lombardi D., Ruggiero M., Aaronson S.A. Tyrosine mutations within the α platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction. Mol. Cell. Biol. 11:1991;3780-3785.
23. Hayashi N., Takehara K., Soma Y. Differential chemotactic responses mediated by platelet-derived growth factor α- and β-receptors. Arch. Biochem. Biophys. 322:1995;423-428.
24. Diliberto P.A., Gordon G.W., Yu C.-L., Earp H.S., Herman B. Platelet-derived growth factor (PDGF) α receptor activation modulates the calcium mobilizing activity of the PDGF β receptor in Balb/c3T3 fibroblasts. J. Biol. Chem. 267:1992;11888-11897.
25. 2+ signaling in the CG4 oligodendroglial cell line and in transformed oligodendrocytes expressing the β-PDGF receptor. J. Biol. Chem. 272:1997;4351-4358.
26. Hossain M.Z., Ao P., Boynton A.L. Rapid disruption of gap junctional communication and phosphorylation of connexin43 by platelet-derived growth factor in T51B rat liver epithelial cells expressing platelet-derived growth factor receptor. J. Cell. Physiol. 174:1998;66-77.
27. Tian W.-N., Pignatare J.N., Stanton R.C. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J. Biol. Chem. 269:1994;14798-14805.
28. Nikkhah G., Odin P., Smits A., Tingström A., Othberg A., Brundin P., Funa K., Lindvall O. Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp. Brain Res. 92:1993;516-523.
29. Funa K., Åhgren A. Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF β-receptor RNA. Cell Growth Diff. 8:1997;861-869.
30. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95:1995;2266-2274.
31. Yao R., Cooper G.M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2006.
32. Simm A., Hoppe V., Gazit A., Hoppe J. Platelet-derived growth factor isoforms prevent cell death during starvation of AKR-2B fibroblasts. J. Cell. Physiol. 160:1994;295-302.
33. Haniu M., Rohde M.F., Kenney W.C. Disulfide bonds in recombinant human platelet-derived growth factor BB dimer: characterization of intermolecular and intramolecular disulfide linkages. Biochemistry. 32:1993;2431-2437.
34. Jaumann M., Hoppe V., Tatje D., Eichner W., Hoppe J. On the structure of platelet-derived growth factor AA: C-terminal processing, epitopes, and characterization of cysteine residues. Biochemistry. 30:1991;3303-3309.
35. Andersson M., Östman A., Bäckström G., Hellman U., George-Nascimento C., Westermark B., Heldin C.-H. Assignment of interchain disulfide bonds in platelet-derived growth factor (PDGF) and evidence for agonist activity of monomeric PDGF. J. Biol. Chem. 267:1992;11260-11266.
36. Oefner C., D'Arcy A., Winkler F.K., Eggimann B., Hosang M. Crystal structure of human platelet-derived growth factor BB. EMBO J. 11:1992;3921-3926.
37. Östman A., Andersson M., Bäckström G., Heldin C.-H. Assignment of intrachain disulfide bonds in platelet-derived growth factor B-chain. J. Biol. Chem. 268:1993;13372-13377.
38. Muller Y.A., Li B., Christinger H.W., Wells J.A., Cunningham B.C., de Vos A.M. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc. Natl. Acad. Sci. USA. 94:1997;7192-7197.
39. Murray-Rust J., McDonald N.Q., Blundell T.L., Hosang M., Oefner C., Winkler F., Bradshaw R.A. Topological similarities in TGF-β2, PDGF-BB and NGF define a superfamily of polypeptide growth factors. Structure. 1:1993;153-159.
40. 161) is required for receptor binding and mitogenic activity of the PDGF-AA homodimer. J. Biol. Chem. 268:1993;10482-10489.
41. Andersson M., Östman A., Kreysing J., Bäckström G., van de Poll M., Heldin C.-H. Involvement of loop 2 of platelet-derived growth factor-AA and -BB in receptor binding. Growth Factors. 12:1995;159-164.
42. Östman A., Andersson M., Hellman U., Heldin C.-H. Identification of three amino acids in the platelet-derived growth factor (PDGF) B-chain that are important for binding to the PDGF β-receptor. J. Biol. Chem. 266:1991;10073-10077.
43. LaRochelle W.J., Pierce J.H., May-Siroff M., Giese N., Aaronson S.A. Five PDGF B amino acid substitutions convert PDGF A to a PDGF B-like transforming molecule. J. Biol. Chem. 267:1992;17074-17077.
44. Clements J.M., Bawden L.J., Bloxidge R.E., Catlin G., Cook A.L., Craig S., Drummond A.H., Edwards R.M., Fallon A., Green D.R., Hellewell P.G., Kirwin P.M., Nayee P.D., Richardson S.J., Brown D., Chahwala S.B., Snarey M., Winslow D. Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation. EMBO J. 10:1991;4113-4120.
45. Jaumann M., Tatje D., Hoppe J. Identification of individual amino acids in platelet-derived growth factor that contribute to the specificity towards the β-type receptor. FEBS Lett. 302:1992;265-268.
46. Heldin C.-H., Östman A. Ligand-induced dimerization of growth factor receptors: variations on the theme. Cytokines Growth Factor Rev. 7:1996;3-10.
47. Fretto L.J., Snape A.J., Tomlinson J.E., Seroogy J.J., Wolf D.L., LaRochelle W.J., Giese N.A. Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to α and β PDGF receptor. J. Biol. Chem. 268:1993;3625-3631.
48. Herren B., Rooney B., Weyer K.A., Iberg N., Schmid G., Pech M. Dimerization of extracellular domains of platelet-derived growth factor receptors. J. Biol. Chem. 268:1993;15088-15095.
49. Duan D.-S.R., Pazin M.J., Fretto L.J., Williams L.T. A functional soluble extracellular region of the platelet-derived growth factor (PDGF) β-receptor antagonizes PDGF-stimulated responses. J. Biol. Chem. 266:1991;413-418.
50. Bishayee S., Majumdar S., Khire J., Das M. Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation. J. Biol. Chem. 264:1989;11699-11705.
51. Heldin C.-H., Ernlund A., Rorsman C., Rönnstrand L. Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. J. Biol. Chem. 264:1989;8905-8912.
52. Seifert R.A., Hart C.E., Philips P.E., Forstrom J.W., Ross R., Murray M., Bowen-Pope D.F. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J. Biol. Chem. 264:1989;8771-8778.
53. Kanakaraj P., Raj S., Khan S.A., Bishayee S. Ligand-induced interaction between α- and β-type platelet derived growth factor (PDGF) receptors: role of receptor heterodimers in kinase activation. Biochemistry. 30:1991;1761-1767.
54. Hammacher A., Mellström K., Heldin C.-H., Westermark B. Isoform-specific induction of actin reorganization by platelet-derived growth factor suggests that the functionally active receptor is a dimer. EMBO J. 8:1989;2489-2495.
55. Drozdoff V., Pledger W.J. Cellular response to platelet-derived growth factor (PDGF)-AB after down-regulation of PDGF α-receptors. J. Biol. Chem. 266:1991;17165-17172.
56. Inui H., Kitami Y., Kondo T., Inagami T. Transduction of mitogenic activity of platelet-derived growth factor (PDGF) AB by PDGF-β receptor without participation of PDGF-α receptor in vascular smooth muscle cells. J. Biol. Chem. 268:1993;17045-17050.
57. Seifert R.A., van Koppen A., Bowen-Pope D.F. PDGF-AB requires PDGF receptor α-subunits for high-affinity, but not for low-affinity, binding and signal transduction. J. Biol. Chem. 268:1993;4473-4480.
58. Yarden Y., Escobedo J.A., Kuang W.-J., Yang-Feng T.L., Daniel T.O., Tremble P.M., Chen E.Y., Ando M.E., Harkins R.N., Francke U., Friend V.A., Ullrich A., Williams L.T. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature. 323:1986;226-232.
59. Claesson-Welsh L., Eriksson A., Westermark B., Heldin C.-H. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc. Natl. Acad. Sci. USA. 86:1989;4917-4921.
60. Matsui T., Heidaran M., Miki T., Toru M., Popescu N., La Rochelle W., Kraus M., Pierce J., Aaronson S.A. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science. 243:1989;800-803.
61. Heidaran M.A., Pierce J.H., Jensen R.A., Matsui T., Aaronson S.A. Chimeric α- and β-platelet-derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the α-PDGF receptor that determine PDGF-AA binding specificity. J. Biol. Chem. 265:1990;18741-18744.
62. Yu J.C., Mahadevan D., LaRochelle W.J., Pierce J.H., Heidaran M.A. Structural coincidence of alphaPDGFR epitopes binding to platelet-derived growth factor-AA and a potent neutralizing monoclonal antibody. J. Biol. Chem. 269:1994;10668-10674.
63. Wiesmann C., Fuh G., Christinger H.W., Eigenbrot C., Wells J.A., de Vos A.M. Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell. 91:1997;695-704.
64. Mahadevan D., Yu J.-C., Saldanha J.W., Thanki N., McPhie P., Uren A., LaRochelle W.J., Heidaran M.A. Structural role of extracellular domain 1 of α-platelet-derived growth factor (PDGF) receptor for PDGF-AA and PDGF-BB binding. J. Biol. Chem. 270:1995;27595-27600.
65. Lokker N.A., O'Hare J.P., Barsoumian A., Tomlinson J.E., Ramakrishnan V., Fretto L.J., Giese N.A. Functional importance of platelet-derived growth factor (PDGF) receptor extracellular immunoglobulin-like domains. Identification of PDGF binding site and neutralizing monoclonal antibodies. J. Biol. Chem. 272:1997;33037-33044.
66. Heidaran M.A., Yu J.-C., Jensen R.A., Pierce J.H., Aaronson S.A. A deletion in the extracellular domain of the α platelet-derived growth factor (PDGF) receptor differentially impairs PDG-AA and PDGF-BB binding affinities. J. Biol. Chem. 267:1992;2884-2887.
67. Vassbotn F.S., Östman A., Siegbahn A., Holmsen H., Heldin C.-H. Neomycin is a platelet-derived growth factor (PDGF) antagonist that allows discrimination of PDGF α- and β-receptor signals in cells expressing both receptor types. J. Biol. Chem. 267:1992;15635-15641.
68. Omura T., Heldin C.-H., Östman A. Immunoglobulin-like domain 4-mediated receptor-receptor interactions contribute to platelet-derived growth factor-induced receptor dimerization. J. Biol. Chem. 272:1997;12676-12682.
69. Shulman T., Sauer F.G., Jackman R.M., Chang C.N., Landolfi N.F. An antibody reactive with domain 4 of the platelet-derived growth factor β receptor allows BB binding while inhibiting proliferation by impairing receptor dimerization. J. Biol. Chem. 272:1997;17400-17404.
70. Blechman J.M., Lev S., Barg J., Eisenstein M., Vaks B., Vogel Z., Givol D., Yarden Y. The fourth immunoglobin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell. 80:1995;105-115.
71. Barleon B., Totzke F., Herzog C., Blanke S., Kremmer E., Siemeister G., Marmé D., Martiny-Baron G. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain. J. Biol. Chem. 272:1997;10382-10388.
72. Cunningham B.C., Ultsch M., De Vos A.M., Mulkerrin M.G., Clausner K.R., Wells J.A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 254:1991;821-825.
73. De Vos A.M., Ultsch M., Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 255:1992;306-312.
74. Jensen R.A., Beeler J.F., Heidaran M.A., LaRochelle W.J. Characterization of baculovirus-expressed human α and β platelet-derived growth factor receptors. Biochemistry. 31:1992;10887-10892.
75. Kelly J.D., Haldeman B.A., Grant F.J., Murray M.J., Seifert R.A., Bowen-Pope D.F., Cooper J.A., Kazlauskas A. Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J. Biol. Chem. 266:1991;8987-8992.
76. Fantl W.J., Escobedo J.A., Williams L.T. Mutations of the platelet-derived growth factor receptor that cause a loss of ligand-induced conformational change, subtle changes in kinase activity, and impaired ability to stimulate DNA synthesis. Mol. Cell. Biol. 9:1989;4473-4478.
77. Kazlauskas A., Cooper J.A. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell. 58:1989;1121-1133.
78. White M.F., Shoelson S.E., Keutmann H., Kahn C.R. A cascade of tyrosine autophosphorylation in the β-subunit activates the phosphotransferase of the insulin receptor. J. Biol. Chem. 263:1988;2969-2980.
79. Naldini L., Vigna E., Ferracini R., Longati P., Gandino L., Prat M., Comoglio P.M. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation. Mol. Cell. Biol. 11:1991;1793-1803.
80. Mohammadi M., Dikic I., Sorokin A., Burgess W.H., Jaye M., Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:1996;977-989.
81. Mohammadi M., Schlessinger J., Hubbard S.R. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell. 86:1996;577-587.
82. Guiton M., Gunn-Moore F.J., Stitt T.N., Yancopoulos G.D., Tavare J.M. Identification of in vivo brain-derived neurotrophic factor-stimulated autophosphorylation sites on the TrkB receptor tyrosine kinase by site-directed mutagenesis. J. Biol. Chem. 269:1994;30370-30377.
83. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J. Biol. Chem. 269:1994;32023-32026.
84. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:1997;2075-2080.
85. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., Neel B.G., Birge R.B., Fajardo J.E., Chou M.M., Hanafusa H., Schaffhausen B., Cantley L.C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
86. Herbst R., Shearman M.S., Jallal B., Schlessinger J., Ullrich A. Formation of signal transfer complexes between stem cell and platelet-derived growth factor receptors and SH2 domain proteins in vitro. Biochemistry. 34:1995;5971-5979.
87. Bonita D.P., Miyake S., Lupher M.L. Jr., Langdon W.Y., Band H. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor α signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity. Mol. Cell. Biol. 17:1997;4597-4610.
88. G. Panayotou, Multiple roles for phosphoinositide 3-kinase in signal transduction, in: C.-H. Heldin, M. Purton (Eds.), Modular Texts in Molecular and Cell Biology: Signal Transduction, Vol. 1, Chapman and Hall, London, 1996, pp. 189-204.
89. Auger K.R., Serunian L.A., Soltoff S.P., Libby P., Cantley L.C. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell. 57:1989;167-175.
90. Coughlin S.R., Escobedo J.A., Williams L.T. Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science. 243:1989;1191-1194.
91. Fantl W.J., Escobedo J.A., Martin G.A., Turck C.W., del Rosario M., McCormick F., Williams L.T. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell. 69:1992;413-423.
92. Kazlauskas A., Kashishian A., Cooper J.A., Valius M. GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor β subunit. Mol. Cell. Biol. 12:1992;2534-2544.
93. Kashishian A., Kazlauskas A., Cooper J.A. Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. EMBO J. 11:1992;1373-1382.
94. Kavanaugh W.M., Turck C.W., Klippel A., Williams L.T. Tyrosine 508 of the 85-kilodalton subunit of phosphatidylinositol 3-kinase is phosphorylated by the platelet-derived growth factor receptor. Biochemistry. 33:1994;11046-11050.
95. Panayotou G., Bax B., Gout I., Federwisch M., Wroblowski B., Dhand R., Fry M.J., Blundell T.L., Wollmer A., Waterfield M.D. Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes. EMBO J. 11:1992;4261-4272.
96. Backer J.M., Myers M.G. Jr., Shoelson S.E., Chin D.J., Sun X.J., Miralpeix M., Hu P., Margolis B., Scolnik E.Y., Schlessinger J., White M.F. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:1992;3469-3479.
97. Whiteford C.C., Best C., Kazlauskas A., Ulug E.T. D-3 phosphoinositide metabolism in cells treated with platelet-derived growth factor. Biochem. J. 319:1996;851-860.
98. Burgering B.M.T., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599-602.
99. Franke T.F., Yang S.-I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., Kaplan D.R., Tsichlis P.N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:1995;727-736.
100. Klippel A., Kavanaugh W.M., Pot D., Williams L.T. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17:1997;338-344.
101. Moriya S., Kazlauskas A., Akimoto K., Hirai S.-i., Mizuno K., Takenawa T., Fukui Y., Watanabe Y., Ozaki S., Ohno S. Platelet-derived growth factor activates protein kinase Cε through redundant and independent signaling pathways involving phospholipase Cγ or phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA. 93:1996;151-155.
102. Nakanishi H., Brewer K.A., Exton J.H. Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268:1993;13-16.
103. A. Toker, M. Meyer, K.K. Reddy, J.R. Falck, R. Aneja, S. Aneja, A. Parra, D.J. Burns, L.M. Ballas, L.C. Cantley, Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3. J. Biol. Chem. 269 (1994).
104. Akimoto K., Takahashi R., Moriya S., Nishioka N., Takayanagi J., Kimura K., Fukui Y., Osada S., Mizuno K., Hirai S., Kazlauskas A., Ohno S. EGF or PDGF receptors activate atypical PKC lambda through phosphatidylinositol 3-kinase. EMBO J. 15:1996;788-798.
105. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:1994;4902-4911.
106. S6k activation mediated by phosphatidyl-inositol-3-OH kinase. Nature. 370:1994;71-75.
107. Lopez-Ilasaca M., Li W., Uren A., Yu J.-c., Kazlauskas A., Gutkind J.S., Heidaran M.A. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF. Biochem. Biophys. Res. Commun. 232:1997;273-277.
108. Hawkins P.T., Eguinoa A., Qiu R.-G., Stokoe D., Cooke F.T., Walters R., Wennström S., Claesson-Welsh L., Evans T., Symons M., Stephens L. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr. Biol. 5:1995;393-403.
109. Stokoe D., Stephens L.R., Copeland T., Gaffney P.R.J., Reese C.B., Painter G.F., Holmes A.B., McCormick F., Hawkins P.T. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 277:1997;567-570.
110. Franke T.F., Kaplan D.R., Cantley L.C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 275:1997;665-668.
111. Kamohara S., Hayashi H., Todaka M., Kanai F., Ishii K., Imanaka T., Escobedo J.A., Williams L.T., Ebina Y. Platelet-derived growth factor triggers translocation of the insulin-regulatable glucose transporter (type 4) predominantly through phosphatidylinositol 3-kinase binding sites on the receptor. Proc. Natl. Acad. Sci. USA. 92:1995;1077-1081.
112. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
113. Kamat A., Carpenter G. Phospholipase C-γ1: Regulation of enzyme function and role in growth factor-dependent signal transduction. Cytokine Growth Factor Rev. 8:1997;109-117.
114. 2. Mol. Cell. Biol. 11:1991;2018-2025.
115. Ji Q.-S., Winnier G.E., Niswender K.D., Horstman D., Wisdom R., Magnuson M.A., Carpenter G. Essential role of the tyrosine kinase substrate phospholipase C-γ1 in mammalian growth and development. Proc. Natl. Acad. Sci. USA. 94:1997;2999-3003.
116. Rönnstrand L., Mori S., Arvidsson A.-K., Eriksson A., Wernstedt C., Hellman U., Claesson-Welsh L., Heldin C.-H. Identification of two C-terminal autophosphorylation sites in the PDGF β-receptor: involvement in the interaction with phospholipase C-γ EMBO J. 11:1992;3911-3919.
117. Kashishian A., Cooper J.A. Phosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase Cγ1. Mol. Biol. Cell. 4:1993;49-57.
118. Valius M., Bazenet C., Kazlauskas A. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor β subunit and are required for binding of phospholipase Cγ and a 64-kilodalton protein, respectively. Mol. Cell. Biol. 13:1993;133-143.
119. Eriksson A., Nånberg E., Rönnstrand L., Engström U., Hellman U., Rupp E., Carpenter G., Heldin C.-H., Claesson-Welsh L. Demonstration of functionally different interactions between phospholipase C-γ and the two types of platelet-derived growth factor receptors. J. Biol. Chem. 270:1995;7773-7781.
120. Kumjian D.A., Barnstein A., Rhee S.G., Daniel T.O. Phospholipase Cg complexes with ligand-activated platelet-derived growth factor (PDGF) receptors. J. Biol. Chem. 266:1991;3973-3980.
121. Morrison D.K., Kaplan D.R., Rhee S.G., Williams L.T. Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-γ with the PDGF receptor signaling complex. Mol. Cell. Biol. 10:1990;2359-2366.
122. Meisenhelder J., Suh P.-G., Rhee S.G., Hunter T. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein tyrosine kinases in vivo and in vitro. Cell. 57:1989;1109-1122.
123. Wahl M.I., Olashaw N.E., Nishibe S., Rhee S.G., Pledger W.J., Carpenter G. Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-γ in quiescent BALB/c 3T3 cells. Mol. Cell. Biol. 9:1989;2934-2943.
124. Margolis B., Zilberstein A., Franks C., Felder S., Kremer S., Ullrich A., Rhee S.G., Skorecki K., Schlessinger J. Effect of phospholipase C-γ overexpression on PDGF-induced second messengers and mitogenesis. Science. 248:1990;607-610.
125. Nishibe S., Wahl M.I., Hernandez-Sotomayor S.M.T., Tonks N.K., Rhee S.G., Carpenter G. Increase of the catalytic activity of phospholipase C-γ1 by tyrosine phosphorylation. Science. 250:1990;1253-1256.
126. Kim J.W., Sim S.S., Kim U.-H., Nishibe S., Wahl M.I., Carpenter G., Rhee S.G. Tyrosine residues in bovine phospholipase C-γ phosphorylated by the epidermal growth factor receptor in vitro. J. Biol. Chem. 265:1990;3940-3943.
127. Yeo E.-J., Provost J.J., Exton J.H. Dissociation of tyrosine phosphorylation and activation of phosphoinositide phospholipase C induced by the protein kinase C inhibitor Ro-31-8220 in Swiss 3T3 cells treated with platelet-derived growth factor. Biochim. Biophys. Acta. 1356:1997;308-320.
128. Falasca M., Logan S.K., Lehto V.P., Baccante G., Lemmon M.A., Schlessinger J. Activation of phospholipase Cγ by PI3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 17:1998;414-422.
129. Lee Y.H., Kim H.S., Pai J.K., Ryu S.H., Suh P.G. Activation of phospholipase D induced by platelet-derived growth factor is dependent upon the level of phospholipase C-gamma1. J. Biol. Chem. 269:1994;26842-26847.
130. Yeo E.J., Kazlauskas A., Exton J.H. Activation of phospholipase C-γ is necessary for stimulation of phospholipase D by platelet-derived growth factor. J. Biol. Chem. 269:1994;27823-27826.
131. Jones G.A., Carpenter G. The regulation of phospholipase C-γ 1 by phosphatidic acid. J. Biol. Chem. 268:1993;20845-20850.
132. Fukami K., Takenawa T. Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal. J. Biol. Chem. 267:1992;10988-10993.
133. Plevin R., Cook S.J., Palmer S., Wakelam M.J. Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth-factor-stimulated Swiss 3T3 fibroblasts. Evidence for activation of phosphoinositidase C and phosphatidyl-choline-specific phospholipase D. Biochem. J. 279:1991;559-565.
134. Ben-Av P., Liscovitch M. Phospholipase D activation by the mitogens platelet-derived growth factor and 12-O-tetradecanoylphorbol 13-acetate in NIH-3T3 cells. FEBS Lett. 259:1989;64-66.
135. Song J., Foster D.A. v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters. Biochem. J. 294:1993;711-717.
136. + exchange by platelet-derived growth factor involves phosphatidylinositol 3′-kinase and phospholipase Cγ J. Biol. Chem. 269:1994;30734-30739.
137. Schlessinger J. How receptor tyrosine kinases activate Ras. Trends Biol. Sci. 18:1993;273-275.
138. Satoh T., Fantl W.J., Escobedo J.A., Williams L.T., Kaziro Y. Platelet-derived growth factor receptor mediates activation of Ras through different signaling pathways in different cell types. Mol. Cell. Biol. 13:1993;3706-3713.
139. Nånberg E., Westermark B. Platelet-derived growth factor increases the turnover of GTP/GDP on Ras in permeabilized fibroblasts. J. Biol. Chem. 268:1993;18187-18194.
140. Arvidsson A.-K., Rupp E., Nånberg E., Downward J., Rönnstrand L., Wennström S., Schlessinger J., Heldin C.-H., Claesson-Welsh L. Tyr-716 in the platelet-derived growth factor β-receptor kinase insert is involved in GRB2 binding and Ras activation. Mol. Cell. Biol. 14:1994;6715-6726.
141. Ruusala A., Sundberg C., Arvidsson A.-K., Rupp-Thuresson E., Heldin C.-H., Claesson-Welsh L. Platelet-derived growth factor (PDGF)-induced actin rearrangement is deregulated in cells expressing a mutant Y778F PDGF β-receptor. J. Cell Sci. 111:1998;111-120.
142. Benjamin C.W., Jones D.A. Platelet-derived growth factor stimulates growth factor receptor binding protein-2 association with Shc in vascular smooth muscle cells. J. Biol. Chem. 269:1994;30911-30916.
143. Yokote K., Mori S., Hansen K., McGlade J., Pawson T., Heldin C.-H., Claesson-Welsh L. Direct interaction between Shc and the platelet-derived growth factor β-receptor. J. Biol. Chem. 269:1994;15337-15343.
144. Li W., Nishimura R., Kashishian A., Batzer A.G., Kim W.J.H., Cooper J.A., Schlessinger J. A new function for a phosphotyrosine phosphatase: Linking GRB2-Sos to a receptor tyrosine kinase. Mol. Cell. Biol. 14:1994;509-517.
145. Erpel T., Courtneidge S.A. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7:1995;176-182.
146. Kypta R.M., Goldberg Y., Ulug E.T., Courtneidge S.A. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell. 62:1990;481-492.
147. Mori S., Rönnstrand L., Yokote K., Engström Å., Courtneidge S.A., Claesson-Welsh L., Heldin C.-H. Identification of two juxtamembrane autophosphorylation sites in the PDGF β-receptor; involvement in the interaction with Src family tyrosine kinases. EMBO J. 12:1993;2257-2264.
148. Gelderloos J.A., Rosenkranz S., Bazenet C., Kazlauskas A. A role for Src in signal relay by the platelet-derived growth factor α receptor. J. Biol. Chem. 273:1998;5908-5915.
149. Hooshmand-Rad R., Yokote K., Heldin C.-H., Claesson-Welsh L. PDGF α-receptor mediated cellular responses are not dependent on Src family kinases in endothelial cells. J. Cell Sci. 111:1998;607-614.
150. Alonso G., Koegl M., Mazurenko N., Courtneidge S.A. Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors. J. Biol. Chem. 270:1995;9840-9848.
151. Stover D.R., Furet P., Lydon N.B. Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain. J. Biol. Chem. 271:1996;12481-12487.
152. Broome M.A., Hunter T. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding. Oncogene. 14:1997;17-34.
153. Hansen K., Alonso G., Courtneidge S.A., Rönnstrand L., Heldin C.-H. PDGF-induced phosphorylation of Tyr28 in the N-terminus of Fyn affects Fyn activation. Biochem. Biophys. Res. Commun. 241:1997;355-362.
154. Barone M.V., Courtneidge S.A. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature. 378:1995;509-512.
155. Twamley-Stein G.M., Pepperkok R., Ansorge W., Courtneidge S.A. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA. 90:1993;7696-7700.
156. Kim L., Wong T.W. The cytoplasmic tyrosine kinase FER is associated with the catenin-like substrate pp120 and is activated by growth factors. Mol. Cell. Biol. 15:1995;4553-4561.
157. Darnell J.E. Jr. STATs and gene regulation. Science. 277:1997;1630-1635.
158. Yamamoto H., Crow M., Cheng L., Lakatta E., Kinsella J. PDGF receptor-to-nucleus signaling of p91 (STAT1α) transcription factor in rat smooth muscle cells. Exp. Cell Res. 222:1996;125-130.
159. Choudhury G.G., Marra F., Kiyomoto H., Abboud H.E. PDGF stimulates tyrosine phosphorylation of JAK 1 protein tyrosine kinase in human mesangial cells. Kidney Int. 49:1996;19-25.
160. Vignais M.-L., Sadowski H.B., Watling D., Rogers N.C., Gilman M. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol. Cell. Biol. 16:1996;1759-1769.
161. Valgeirsdóttir S., Paukku K., Silvennoinen O., Heldin C.-H., Claesson-Welsh L. Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF β-receptor juxtamembrane and kinase insert domains. Oncogene. 16:1998;505-515.
162. Novak U., Mui A., Miyajima A., Paradiso L. Formation of STAT5-containing DNA binding complexes in response to colony-stimulating factor-1 and platelet-derived growth factor. J. Biol. Chem. 271:1996;18350-18354.
163. Cirri P., Chiarugi P., Marra F., Raugei G., Camici G., Manao G., Ramponi G. c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. Biochem. Biophys. Res. Commun. 239:1997;493-497.
164. Lechleider R.J., Sugimoto S., Bennett A.M., Kashishian A.S., Cooper J.A., Shoelson S.E., Walsh C.T., Neel B.G. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor β J. Biol. Chem. 268:1993;21478-21481.
165. Kazlauskas A., Feng G.-S., Pawson T., Valius M. The 64-kDa protein that associates with the platelet-derived growth factor receptor β subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc. Natl. Acad. Sci. USA. 90:1993;6939-6943.
166. Bazenet C.E., Gelderloos J.A., Kazlauskas A. Phosphorylation of tyrosine 720 in the platelet-derived growth factor α receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation. Mol. Cell. Biol. 16:1996;6926-6936.
167. Pluskey S., Wandless T.J., Walsh C.T., Shoelson S.E. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J. Biol. Chem. 270:1995;2897-2900.
168. Bennett A.M., Tang T.L., Sugimoto S., Walsh C.T., Neel B.G. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras. Proc. Natl. Acad. Sci. USA. 91:1994;7335-7339.
169. Vogel W., Ullrich A. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584. Cell Growth Differ. 7:1996;1589-1597.
170. Klinghoffer R.A., Kazlauskas A. Identification of a putative Syp substrate, the PDGFβ receptor. J. Biol. Chem. 270:1995;22208-22217.
171. Cossette L.J., Hoglinger O., Mou L., Shen S.-H. Localization and down-regulating role of the protein tyrosine phosphatase PTP2C in membrane ruffles of PDGF-stimulated cells. Exp. Cell Res. 223:1996;459-466.
172. 2-terminal mitogen-activated protein kinases. J. Biol. Chem. 273:1998;4904-4908.
173. Rivard N., McKenzie F.R., Brondello J.-M., Pouysségur J. The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors. J. Biol. Chem. 270:1995;11017-11024.
174. Peng Z.-Y., Cartwright C.A. Regulation of the Src tyrosine kinase and Syp tyrosine phosphatase by their cellular association. Oncogene. 11:1995;1955-1962.
175. Somani A.-K., Bignon J.S., Mills G.B., Siminovitch K.A., Branch D.R. Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J. Biol. Chem. 272:1997;21113-21119.
176. Stokoe D., McCormick F. Activation of c-Raf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro. EMBO J. 16:1997;2384-2396.
177. Marais R., Light Y., Paterson H.F., Marshall C.J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:1995;3136-3145.
178. Marais R., Light Y., Paterson H.F., Mason C.S., Marshall C.J. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic Ras and tyrosine kinases. J. Biol. Chem. 272:1997;4378-4383.
179. Bazenet C.E., Kazlauskas A. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP. Oncogene. 9:1994;517-525.
180. Heidaran M.A., Beeler J.F., Yu J.-C., Ishibashi T., LaRochelle W.J., Pierce J.H., Aaronson S.A. Differences in substrate specificities of α and β platelet-derived growth factor (PDGF) receptors. J. Biol. Chem. 268:1993;9287-9295.
181. van der Geer P., Henkemeyer M., Jacks T., Pawson T. Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap. Mol. Cell. Biol. 17:1997;1840-1847.
182. Valius M., Secrist J.P., Kazlauskas A. The GTPase-activating protein of Ras suppresses platelet-derived growth factor β receptor signaling by silencing phospholipase C-γ1. Mol. Cell. Biol. 15:1995;3058-3071.
183. Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., Batzer A., Thomas S., Brugge J., Pelicci P.G., Schlessinger J., Pawson T. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 360:1992;689-692.
184. Gotoh N., Toyoda M., Shibuya M. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation. Mol. Cell. Biol. 17:1997;1824-1831.
185. Nishimura R., Li W., Kashishian A., Mondino A., Zhou M., Cooper J., Schlessinger J. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. Mol. Cell. Biol. 13:1993;6889-6896.
186. Bokoch G.M., Wang Y., Bohl B.P., Sells M.A., Quilliam L.A., Knaus U.G. Interaction of the Nck adapter protein with p21-activated kinase (PAK1). J. Biol. Chem. 271:1996;25746-25749.
187. Su Y.C., Han J., Xu S., Cobb M., Skolnik E.Y. NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain. EMBO J. 16:1997;1279-1290.
188. Garrity P.A., Rao Y., Salecker I., McGlade J., Pawson T., Zipursky S.L. Drosophila photoreceptor axon guidance and targeting requires the dreadlocks SH2/SH3 adapter protein. Cell. 85:1996;639-650.
189. Stein D., Wu J., Fuqua S.A.W., Roonprapunt C., Yajnik V., D'Eustachio P., Moskow J.J., Buchberg A.M., Osborne C.K., Margolis B. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J. 13:1994;1331-1340.
190. Yokote K., Margolis B., Heldin C.-H., Claesson-Welsh L. Grb7 is a downstream signaling component of platelet-derived growth factor α- and β-receptors. J. Biol. Chem. 271:1996;30942-30949.
191. Frantz J.D., Giorgetti-Peraldi S., Ottinger E.A., Shoelson S.E. Human GRB-IRβ/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. J. Biol. Chem. 272:1997;2659-2667.
192. Daly R.J., Sanderson G.M., Janes P.W., Sutherland R.L. Cloning and characterization of GRB14, a novel member of the GRB7 gene family. J. Biol. Chem. 271:1996;12502-12510.
193. Birge R.B., Knudsen B.S., Besser D., Hanafusa H. SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction. Genes Cells. 1:1996;595-613.
194. K. Yokote, U. Hellman, Y. Saito, S. Ekman, L. Rönnstrand, Y. Saito, C.-H. Heldin, S. Mori, Identification of Tyr-762 in the platelet-derived growth factor α-receptor as the binding site for Crk proteins, Oncogene, in press.
195. Casamassima A., Rozengurt E. Tyrosine phosphorylation of p130cas by bombesin, lysophosphatidic acid, phorbol esters, and platelet-derived growth factor - signaling pathways and formation of A p130cas-Crk complex. J. Biol. Chem. 272:1997;9363-9370.
196. Tanaka S., Ouchi T., Hanafusa H. Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G. Proc. Natl. Acad. Sci. USA. 94:1997;2356-2361.
197. Hansen K., Rönnstrand L., Claesson-Welsh L., Heldin C.-H. Phosphorylation of a 72-kDa protein in PDGF-stimulated cells which forms complex with c-Crk, c-Fyn and Eps15. FEBS Lett. 409:1997;195-200.
198. Takeshita T., Arita T., Higuchi M., Asao H., Endo K., Kuroda H., Tanaka N., Murata K., Ishii N., Sugamura K. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity. 6:1997;449-457.
199. Li W., Yu J.-C., Michieli P., Beeler J.F., Ellmore N., Heidaran M.A., Pierce J.H. Stimulation of the platelet-derived growth factor β receptor signaling pathway activates protein kinase C-δ Mol. Cell. Biol. 14:1994;6727-6735.
200. Li W., Michieli P., Alimandi M., Lorenzi M.V., Wu Y., Wang L.H., Heidaran M.A., Pierce J.H. Expression of an ATP binding mutant of PKC-δ inhibits Sis-induced transformation of NIH3T3 cells. Oncogene. 13:1994;731-737.
201. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 370:1994;527-532.
202. Klinghoffer R.A., Duckworth B., Valius M., Cantley L., Kazlauskas A. Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity. Mol. Cell. Biol. 16:1996;5905-5914.
203. Hu Q., Klippel A., Muslin A.J., Fantl W.J., Williams L.T. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science. 268:1995;100-102.
204. Olson M.F., Ashworth A., Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science. 269:1995;1270-1272.
205. Qiu R.-G., Chen J., Kirn D., McCormick F., Symons M. An essential role for Rac in Ras transformation. Nature. 374:1995;457-459.
206. Khosravi-Far R., Solski P.A., Clark G.J., Kinch M.S., Der C.J. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15:1995;6443-6453.
207. Qiu R.G., Abo A., McCormick F., Symons M. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol. Cell. Biol. 17:1997;3449-3458.
208. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
209. Stossel T.P. On the crawling of animal cells. Science. 260:1993;1086-1094.
210. Kundra V., Soker S., Zetter B.R. Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB. Oncogene. 9:1994;1429-1435.
211. Hirsch E., Iglesias A., Potocnik A.J., Hartmann U., Fassler R. Impaired migration but not differentiation of hematopoietic stem cells in the absence of β1 integrins. Nature. 380:1996;171-175.
212. Ilic D., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., Nomura S., Fujimoto J., Okada M., Yamamoto T., Aizawa S. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 377:1995;539-544.
213. 1 integrin and disassembly of actin filaments. Circ. Res. 80:1997;627-637.
214. FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin. J. Biol. Chem. 269:1994;704-710.
215. Wennström S., Hawkins P., Cooke F., Hara K., Yonezawa K., Kasuga M., Jackson T., Claesson-Welsh L., Stephens L. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol. 4:1994;385-393.
216. Wennström S., Siegbahn A., Yokote K., Arvidsson A.-K., Heldin C.-H., Mori S., Claesson-Welsh L. Membrane ruffling and chemotaxis transduced by the PDGF β-receptor require the binding site for phosphatidyl-inositol 3′ kinase. Oncogene. 9:1994;651-660.
217. Nobes C.D., Hawkins P., Stephens L., Hall A. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J. Cell Sci. 108:1995;225-233.
218. Ridley A.J., Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 70:1992;389-399.
219. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 70:1992;401-410.
220. Nobes C.D., Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81:1995;53-62.
221. Allen W.E., Jones G.E., Pollard J.W., Ridley A.J. Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J. Cell Sci. 110:1997;707-720.
222. Hooshmand-Rad R., Claesson-Welsh L., Wennström S., Yokote K., Siegbahn A., Heldin C.-H. Involvement of phosphatidylinositide 3′-kinase and Rac in platelet-derived growth factor-induced actin reorganization and chemotaxis. Exp. Cell Res. 234:1997;434-441.
223. M.P. Derman, A. Toker, J.H. Hartwig, K. Spokes, J.R. Falck, C.-S. Chen, L.C. Cantley, L.G. Cantley, The lipid products of phosphoinositide 3-kinase increase cell motility through protein kinase C. J. Biol. Chem. 272 (1997).
224. Higaki M., Sakaue H., Ogawa W., Kasuga M., Shimokado K. Phosphatidylinositol 3-kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J. Biol. Chem. 271:1996;29342-29346.
225. Bornfeldt K.E., Raines E.W., Nakano T., Graves L.M., Krebs E.G., Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93:1994;1266-1274.
226. Kundra V., Escobedo J.A., Kazlauskas A., Kim H.K., Rhee S.G., Williams L.T., Zetter B.R. Regulation of chemotaxis by the platelet-derived growth factor receptor-β Nature. 367:1994;474-476.
227. Hansen K., Johnell M., Siegbahn A., Rorsman C., Engström U., Wernstedt C., Heldin C.-H., Rönnstrand L. Mutation of a Src phosphorylation site in the PDGF β-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis. EMBO J. 15:1996;5299-5313.
228. Bar-Sagi D., Feramisco J.R. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science. 233:1986;1061-1068.
229. Rodriguez-Viciana P., Warne P.H., Khwaja A., Marte B.M., Pappin D., Das P., Waterfield M.D., Ridley A., Downward J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 89:1997;457-467.
230. Kundra V., Anand-Apte B., Feig L.A., Zetter B.R. The chemotactic response to PDGF-BB: evidence of a role for Ras. J. Cell Biol. 130:1995;725-731.
231. Anand-Apte B., Zetter B.R., Viswanathan A., Qiu R.-G., Chen J., Ruggieri R., Symons M. Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways. J. Biol. Chem. 272:1997;30688-30692.
232. Graf K., Xi X.-P., Yang D., Fleck E., Hsueh W.A., Law R.E. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 29:(2):1997;334-339.
233. Koyama N., Morisaki N., Saito Y., Yoshida S. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J. Biol. Chem. 267:1992;22806-22812.
234. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
235. Olivera A., Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature. 365:1993;557-560.
236. Bornfeldt K.E., Graves L.M., Raines E.W., Igarashi Y., Wayman G., Yamamura S., Yatomi Y., Sidhu J.S., Krebs E.G., Hakomori S.-i., Ross R. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J. Cell Biol. 130:1995;193-206.
237. Pyne S., Chapman J., Steele L., Pyne N.J. Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle. Eur. J. Biochem. 237:1996;819-826.
238. Rani C.S.S., Wang F., Fuior E., Berger A., Wu J., Sturgill T.W., Beitner-Johnson D., LeRoith D., Varticovski L., Spiegel S. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling. J. Biol. Chem. 272:1997;10777-10783.
239. van Dijk M.C.M., Hilkmann H., van Blitterswijk W.J. Platelet-derived growth factor activation of mitogen-activated protein kinase depends on the sequential activation of phosphatidylcholine-specific phospholipase C, protein kinase C-ζ and Raf-1. Biochem. J. 325:1997;303-307.
240. Lubinus M., Meier K.E., Smith E.A., Gause K.C., LeRoy E.C., Trojanowska M. Independent effects of platelet-derived growth factor isoforms on mitogen-activated protein kinase activation and mitogenesis in human dermal fibroblasts. J. Biol. Chem. 269:1994;9822-9825.
241. Karenberg T.-A., Fenn A., Sachinidis A., Hoppe J. The differential activation of phosphatidylinositol-3 kinase and mitogen-activated protein kinases by PDGF-AA and IGF-I might explain the synergistic effect of the two growth factors on the proliferation of AKR-2B fibroblasts. Exp. Cell Res. 213:1994;266-274.
242. Thömmes K.B., Hoppe J., Vetter H., Sachinidis A. The synergistic effect of PDGF-AA and IGF-1 on VSMC proliferation might be explained by the differential activation of their intracellular signaling pathways. Exp. Cell Res. 226:1996;59-66.
243. Roche S., McGlade J., Jones M., Gish G.D., Pawson T., Courtneidge S.A. Requirement of phospholipase Cγ, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways. EMBO J. 15:1996;4940-4948.
244. Klippel A., Escobedo J.A., Hirano M., Williams L.T. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol. Cell. Biol. 16:1996;4117-4127.
245. McIlroy J., Chen D., Wjasow C., Michaeli T., Backer J.M. Specific activation of p85-p110 phosphatidylinositol 3′-kinase stimulates DNA synthesis by ras- and p70 S6 kinase-dependent pathways. Mol. Cell. Biol. 17:1997;248-255.
246. Valius M., Kazlauskas A. Phospholipase C-γ1 and phosphatidyl-inositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell. 73:1993;321-334.
247. Wang Z., Glück S., Zhang L., Moran M.F. Requirement for phospholipase C-γ1 enzymatic activity in growth factor-induced mitogenesis. Mol. Cell. Biol. 18:1998;590-597.
248. Homma S., Nagaoka I., Abe H., Takahashi K., Seyama K., Nukiwa T., Kira S. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am. J. Respir. Crit. Care Med. 152:1995;2084-2089.
249. Cuadrado A., Molloy C.J. Overexpression of phospholipase C-gamma in NIH 3T3 fibroblasts results in increased phosphatidylinositol hydrolysis in response to platelet-derived growth factor and basic fibroblast growth factor. Mol. Cell. Biol. 10:1990;6069-6072.
250. Heasley L.E., Johnson G.L. The β-PDGF receptor induces neuronal differentiation of PC12 cells. Mol. Biol. Cell. 3:1992;545-553.
251. Vetter M.L., Bishop J.M. β PDGF receptor mutants defective for mitogenesis promote neurite outgrowth in PC12 cells. Curr. Biol. 5:1995;168-178.
252. Vaillancourt R.R., Heasley L.E., Zamarripa J., Storey B., Valius M., Kazlauskas A., Johnson G.L. Mitogen-activated protein kinase activation is insufficient for growth factor receptor-mediated PC12 cell differentiation. Mol. Cell. Biol. 15:1995;3644-3653.
253. Fanger G.R., Vaillancourt R.R., Heasley L.E., Montmayeur J.-P.R., Johnson G.L., Maue R.A. Analysis of mutant platelet-derived growth factor receptors expressed in PC12 cells identifies signals governing sodium channel induction during neuronal differentiation. Mol. Cell. Biol. 17:1997;89-99.
254. Alimandi M., Heidaran M.A., Gutkind J.S., Zhang J.C., Ellmore N., Valius M., Kazlauskas A., Pierce J.H., Li W. PLC-γ activation is required for PDGF-βR-mediated mitogenesis and monocytic differentiation of myeloid progenitor cells. Oncogene. 15:1997;585-593.
255. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-665.
256. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 385:1997;544-548.
257. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
258. L. Cell. 87:1996;619-628.
259. Downward J. Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8:1998;49-54.
260. sis of simian sarcoma virus. Nature. 304:1983;35-39.
261. Doolittle R.F., Hunkapiller M.W., Hood L.E., Devare S.D., Robbins K.C., Aaronson S.A., Antoniades H.N. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 221:1983;275-277.
262. Simon M.-P., Pedeutour F., Sirvent N., Grosgeorge J., Minoletti F., Coindre J.-M., Terrier-Lacombe M.-J., Mandahl N., Craver R.D., Blin N., Sozzi G., Turc-Carel C., O'Brien K.P., Kedra D., Fransson I., Guilbaud C., Dumanski J.P. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat. Genet. 15:1997;95-98.
263. Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 77:1994;307-316.
264. Carroll M., Tomasson M.H., Barker G.F., Golub T.R., Gilliland D.G. The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways. Proc. Natl. Acad. Sci. USA. 93:1996;14845-14850.
265. Jousset C., Carron C., Boureux A., Quang C.T., Oury C., Dusanter-Fourt I., Charon M., Levin J., Bernard O., Ghysdael J. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein. EMBO J. 16:1997;69-82.
266. Carroll M., Ohno-Jones S., Tamura S., Buchdunger E., Zimmermann J., Lydon N.B., Gilliland D.G., Druker B.J. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood. 90:1997;4947-4952.
267. Abe A., Emi N., Tanimoto M., Terasaki H., Marunouchi T., Saito H. Fusion of the platelet-derived growth factor receptor β to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood. 90:1997;4271-4277.
268. Chi K.D., McPhee R.A., Wagner A.S., Dietz J.J., Pantazis P., Goustin A.S. Integration of proviral DNA into the PDGF β-receptor gene in HTLV-I-infected T-cells results in a novel tyrosine kinase product with transforming activity. Oncogene. 15:1997;1051-1057.
269. Heidaran M.A., Mahadevan D., Larochelle W.J. β PDGFR-IgG chimera demonstrates that human beta PDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding. FASEB J. 9:1995;140-145.
270. Uren A., Yu J.-C., Li W., Chung I.-Y., Mahadevan D., Pierce J.H., Heidaran M.A. Identification of a domain within the carboxyl-terminal region of the β platelet-derived growth factor (PDGF) receptor that mediates the high transforming activity of PDGF. J. Biol. Chem. 271:1996;11051-11054.
271. Yu J.-C., Li W., Wang L.-M., Uren A., Pierce J.H., Heidaran M.A. Differential requirement of a motif within the carboxyl-terminal domain of α-platelet-derived growth factor (αPDGF) receptor for PDGF focus forming activity chemotaxis, or growth. J. Biol. Chem. 270:1995;7033-7036.
272. DeMali K.A., Whiteford C.C., Ulug E.T., Kazlauskas A. Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cγ or phosphatidylinositol 3 kinase. J. Biol. Chem. 272:1997;9011-9018.
273. Petti L.M., Reddy V., Smith S.O., DiMaio D. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein. J. Virol. 71:1997;7318-7327.
274. Meyer A.N., Xu Y.-F., Webster M.K., Smith A.E., Donoghue D.J. Cellular transformation by a transmembrane peptide: Structural requirements for the bovine papillomavirus E5 oncoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;4634-4638.
275. Forsberg K., Valyi-Nagy I., Heldin C.-H., Herlyn M., Westermark B. Platelet-derived growth factor (PDGF) in oncogenesis: Development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. Natl. Acad. Sci. USA. 90:1993;393-397.
276. Porfiri E., McCormick F. Regulation of epidermal growth factor receptor signaling by phosphorylation of the Ras exchange factor hSOS1. J. Biol. Chem. 271:1996;5871-5877.
277. Rozengurt E., Sinnett-Smith J., Taylor-Papadimitriou J. Production of PDGF-like growth factor by breast cancer cell lines. Int. J. Cancer. 36:1985;247-252.
278. Rozengurt E., Stroobant P., Waterfield M.D., Deuel T.F., Keehan M. Platelet-derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: role of prostaglandin production. Cell. 34:1983;265-272.
279. Graves L.M., Bornfeldt K.E., Sidhu J.S., Argast G.M., Raines E.W., Ross R., Leslie C.C., Krebs E.G. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J. Biol. Chem. 271:1996;505-511.
280. Bornfeldt K.E., Campbell J.S., Koyama H., Argast G.M., Leslie C.C., Raines E.W., Krebs E.G., Ross R. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. J. Clin. Invest. 100:1997;875-885.
281. Graves L.M., Bornfeldt K.E., Raines E.W., Potts B.C., Macdonald S.G., Ross R., Krebs E.G. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA. A 90:1993;10300-10304.
282. Plevin R., Malarkey K., Aidulis D., McLees A., Gould G.W. Cyclic AMP inhibits PDGF-stimulated mitogen-activated protein kinase activity in rat aortic smooth muscle cells via inactivation of c-Raf-1 kinase and induction of MAP kinase phosphatase-1. Cell. Signal. 9:1997;323-328.
283. Burgering B.M., Pronk G.J., van Weeren P.C., Chardin P., Bos J.L. cAMP antagonizes p21ras-directed activation of extracellular signal- regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12:1993;4211-4220.
284. Wu J., Dent P., Jelinek T., Wolfman A., Weber M.J., Sturgill T.W. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science. 262:1993;1065-1069.
285. S.J. Cook, F. McCormick, Inhibition by cAMP of Ras-dependent activation of Raf, Science 262 (1993).
286. Graves L.M., Bornfeldt K.E., Argast G.M., Krebs E.G., Kong X., Lin T.A., Lawrence J.C. Jr. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA. 92:1995;7222-7226.
287. Monfar M., Lemon K.P., Grammer T.C., Cheatham L., Chung J., Vlahos C.J., Blenis J. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol. Cell. Biol. 15:1995;326-337.
288. Gagelin C., Pierre M., Toru-Delbauffe D. Inhibition of G1 cyclin expression and G1 cyclin-dependent protein kinases by cAMP in an astrocytic cell line. Biochem. Biophys. Res. Commun. 205:1994;923-929.
289. Kato J.Y., Matsuoka M., Polyak K., Massagué J., Sherr C.J. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell. 79:1994;487-496.
290. r phosphotyrosine protein phosphatase overexpression. FEBS Lett. 349:1994;7-12.
291. r phosphotyrosine protein phosphatase. FEBS Lett. 372:1995;49-53.
292. Mooney R.A., Freund G.G., Way B.A., Bordwell K.L. Expression of a transmembrane phosphotyrosine phosphatase inhibits cellular response to platelet-derived growh factor and insulin-like growth factor-1. J. Biol. Chem. 267:1992;23443-23446.
293. Way B.A., Mooney R.A. Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase. J. Biol. Chem. 268:1993;26409-26415.
294. 2+ and cAMP. FEBS Lett. 391:1996;219-222.
295. Rubin K., Tingström A., Hansson G.K., Larsson E., Rönnstrand L., Klareskog L., Claesson-Welsh L., Heldin C.-H., Fellström B., Terracio L. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet. 1:1988;1353-1356.
296. Terracio L., Rönnstrand L., Tingström A., Rubin K., Claesson-Welsh L., Funa K., Heldin C.-H. Induction of platelet-derived growth factor receptor expression in smooth muscle cells and fibroblasts upon tissue culturing. J. Cell Biol. 107:1988;1947-1957.
297. Barrett T.B., Seifert R.A., Bowen-Pope D.F. Regulation of platelet-derived growth factor receptor expression by cell context overrides regulation by cytokines. J. Cell. Physiol. 169:1996;126-138.
298. Gronwald R.G.K., Seifert R.A., Bowen-Pope D.F. Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-β J. Biol. Chem. 264:1989;8120-8125.
299. Heidaran M.A., Pierce J.H., Yu J.-C., Lombardi D., Artrip J.E., Fleming T.P., Thomason A., Aaronson S.A. Role of αβ receptor heterodimer formation in β platelet-derived growth factor (PDGF) receptor activation by PDGF-AB. J. Biol. Chem. 266:1991;20232-20237.
300. Rupp E., Siegbahn A., Rönnstrand L., Wernstedt C., Claesson-Welsh L., Heldin C.-H. A unique autophosphorylation site in the platelet-derived growth factor α receptor from a heterodimeric receptor complex. Eur. J. Biochem. 225:1994;29-41.
301. Vaillancourt R.R., Gardner A.M., Kazlauskas A., Johnson G.L. The kinase-inactive PDGF β-receptor mediates activation of the MAP kinase cascade via the endogenous PDGF α-receptor in HepG2 cells. Oncogene. 13:1996;151-159.
302. Assoian R.K. Anchorage-dependent cell cycle progression. J. Cell Biol. 136:1997;1-4.
303. Cary L.A., Chang J.F., Guan J.-L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 108:1996;1787-1794.
304. 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J. Cell Biol. 130:1995;441-450.
305. Frisch S.M., Ruoslahti E. Integrins and anoikis. Curr. Opin. Cell Biol. 9:1997;701-706.
306. McNamee H.P., Ingber D.E., Schwartz M.A. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J. Cell Biol. 121:1993;673-678.
307. Schneller M., Vuori K., Ruoslahti E. αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF. EMBO J. 16:1997;5600-5607.
308. 1 integrins on fibroblasts induces PDGF independent tyrosine phosphorylation of PDGF β-receptors. J. Cell Biol. 132:1996;741-752.
309. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: the road taken. Science. 268:1995;233-239.
310. Hanks S.K., Calalb M.B., Harper M.C., Patel S.K. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. USA. 89:1992;8487-8491.
311. FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA. 89:1992;5192-5196.
312. Rankin S., Hooshmand-Rad R., Claesson-Welsh L., Rozengurt E. Requirement for phosphatidylinositol 3′-kinase activity in platelet-derived growth factor-stimulated tyrosine phosphorylation of p125 focal adhesion kinase and paxillin. J. Biol. Chem. 271:1996;7829-7834.
313. Auger K.R., Songyang Z., Lo S.H., Roberts T.M., Chen L.B. Platelet-derived growth factor-induced formation of tensin and phosphoinositide 3-kinase complexes. J. Biol. Chem. 271:1996;23452-23457.
314. 1 Integrin-mediated collagen gel contraction is stimulated by PDGF. Exp. Cell Res. 186:1990;264-272.
315. Lin Y.-C., Grinnell F. Decreased level of PDGF-stimulated receptor autophosphorylation by fibroblasts in mechanically relaxed collagen matrices. J. Cell Biol. 122:1993;663-672.
316. 2-subunit in human diploid fibroblasts. Exp. Cell Res. 215:1994;347-353.
317. 1 integrin synthesis by recombinant platelet-derived growth factor (PDGF-AB) correlates with an enhanced migratory response of human dermal fibroblasts to various extracellular matrix proteins. Exp. Cell Res. 220:1995;29-35.
318. Xu J., Clark R.A.F. Extracellular matrix alters PDGF regulation of fibroblast integrins. J. Cell Biol. 132:1996;239-249.
319. Liu P., Ying Y., Ko Y.-G., Anderson R.G.W. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 271:1996;10299-10303.
320. Wiseman P.W., Höddelius P., Petersen N.O., Magnusson K.-E. Aggregation of PDGF-β receptors in human skin fibroblasts: characterization by image correlation spectroscopy (ICS). FEBS Lett. 401:1997;43-48.
321. Heldin C.-H., Wasteson Å., Westermark B. Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degradation and receptor modulation. J. Biol. Chem. 257:1982;4216-4221.
322. Sorkin A., Westermark B., Heldin C.-H., Claesson-Welsh L. Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF β-receptor. J. Cell Biol. 112:1991;469-478.
323. Mori S., Heldin C.-H., Claesson-Welsh L. Ligand-induced polyubiquitination of the platelet-derived growth factor β-receptor. J. Biol. Chem. 267:1992;6429-6434.
324. Mori S., Tanaka K., Omura S., Saito Y. Degradation process of ligand-stimulated platelet-derived growth factor β-receptor involves ubiquitin-proteasome proteolytic pathway. J. Biol. Chem. 270:1995;29447-29452.
325. Sorkin A., Eriksson A., Heldin C.-H., Westermark B., Claesson-Welsh L. Pool of ligand-bound platelet-derived growth factor β-receptors remain activated and tyrosine phosphorylated after internalization. J. Cell. Physiol. 156:1993;373-382.
326. Mori S., Rönnstrand L., Claesson-Welsh L., Heldin C.-H. A tyrosine residue in the juxtamembrane segment of the platelet-derived growth factor β-receptor is critical for ligand-mediated endocytosis. J. Biol. Chem. 269:1994;4917-4921.
327. Joly M., Kazlauskas A., Fay F.S., Corvera S. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science. 263:1994;684-687.
328. Mori S., Claesson-Welsh L., Heldin C.-H. Identification of a hydrophobic region in the carboxyl terminus of the platelet-derived growth factor β-receptor which is important for ligand-mediated endocytosis. J. Biol. Chem. 266:1991;21158-21164.
329. Westermark B., Heldin C.-H. Similar action of platelet-derived growth factor and epidermal growth factor in the prereplicative phase of human fibroblasts suggests a common intracellular pathway. J. Cell. Physiol. 124:1985;43-48.
330. Mori S., Heldin C.-H., Claesson-Welsh L. Ligand-induced ubiquitination of the platelet-derived growth factor β-receptor plays a negative regulatory role in its mitogenic signaling. J. Biol. Chem. 268:1993;577-583.
331. Coats S.R., Pledger W.J., Awazu M., Daniel T.O. Detergent solubility defines an alternative itinerary for a subpopulation of PDGF β receptors. J. Cell. Physiol. 168:1996;412-423.
332. Ferns G.A.A., Raines E.W., Sprugel K.H., Motani A.S., Reidy M.A., Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1991;1129-1132.
333. Rutherford C., Martin W., Salame M., Carrier M., Änggård E., Ferns G. Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor. Atherosclerosis. 130:1997;45-51.
334. Thyberg J., Östman A., Bäckström G., Westermark B., Heldin C.-H. Localization of platelet-derived growth factor (PDGF) in CHO cells transfected with PDGF A- or B-chain cDNA: retention of PDGF-BB in the endoplasmic reticulum and Golgi complex. J. Cell Sci. 97:1990;219-229.
335. Vassbotn F.S., Langeland N., Hagen I., Holmsen H. A monoclonal antibody against PDGF B-chain inhibits PDGF-induced DNA synthesis in C3H fibroblasts and prevents binding of PDGF to its receptor. Biochim. Biophys. Acta. 1054:1990;246-249.
336. Rooney B.C., Hosang M., Hunziker W. Production of platelet-derived growth factor receptor (PDGFR-beta) in E. coli: mapping ligand binding domain. FEBS Lett. 339:1994;181-184.
337. Green L.S., Jellinek D., Jenison R., Östman A., Heldin C.-H., Janjic N. Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry. 35:1996;14413-14424.
338. Sachinidis A., Kraus R., Seul C., Zu Brickwedde M.K.M., Schulte K., Ko Y., Hoppe J., Vetter H. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms. Eur. J. Cell Biol. 71:1996;79-88.
339. Mullins D.E., Hamud F., Reim R., Davis H.R. Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl-5-chl orobenzene sulfonylphthalimide. Arterioscleros. Thromb. 14:1994;1047-1055.
340. Ramakrishnan V., Escobedo M.-A., Fretto L.J., Seroogy J.J., Tomlinson J.E., Wolf D.L. A novel monoclonal antibody dependent on domain 5 of the platelet-derived growth factor beta receptor inhibits ligand binding and receptor activation. Growth Factors. 8:1993;253-265.
341. LaRochelle W.J., Jensen R.A., Heidaran M.A., May-Siroff M., Wang L.-M., Aaronson S.A., Pierce J.H. Inhibition of platelet-derived growth factor autocrine growth stimulation by a monoclonal antibody to the human α platelet-derived growth factor receptor. Cell Growth Differ. 4:1993;547-553.
342. Engström U., Engström Å., Ernlund A., Westermark B., Heldin C.-H. Identification of a peptide antagonist for platelet-derived growth factor. J. Biol. Chem. 267:1992;16581-16587.
343. Brennand D.M., Dennehy U., Ellis V., Scully M.F., Tripathi P., Kakkar V.V., Patel G. Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts. FEBS Lett. 413:1997;70-74.
344. Williams L.T., Tremble P.M., Lavin M.F., Sunday M.E. Platelet-derived growth factor receptors form a high affinity state in membrane preparations. J. Biol. Chem. 259:1984;5287-5294.
345. Ohnishi H., Yamaguchi K., Shimada S., Suzuki Y., Kumagai A. A new approach to treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor. Life Sci. 31:1982;2595-2602.
346. Klohs W.D., Fry D.W., Kraker A.J. Inhibitors of tyrosine kinase. Curr. Opin. Oncol. 9:1997;562-568.
347. Levitzki A., Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 267:1995;1782-1788.
348. Kovalenko M., Gazit A., Böhmer A., Rorsman C., Rönnstrand L., Heldin C.-H., Waltenberger J., Böhmer F.-D., Levitzki A. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res. 54:1994;6106-6114.
349. Gazit A., App H., McMahon G., Chen J., Levitzki A., Böhmer F.D. Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins. J. Med. Chem. 39:1996;2170-2177.
350. Buchdunger E., Zimmermann J., Mett H., Meyer T., Müller M., Regenass U., Lydon N.B. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc. Natl. Acad. Sci. USA. 92:1995;2558-2562.
351. Sawutz D.G., Bode D.C., Briggs G.M., Reid J.R., Canniff P., Caldwell L., Faltynek C.R., Miller D., Dunn J.A., de Garavilla L., Guiles J.W., Weigelt C., Michne W., Treasurywala A.M., Silver P.J. In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors. Biochem. Pharmacol. 51:1996;1631-1638.
352. Yagi M., Kato S., Kobayashi Y., Kubo K., Oyama S., Shimizu T., Nishitoba T., Isoe T., Nakamura K., Ohashi H., Kobayashi N., Iinuma N., Osawa T., Onose R., Osada H. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative. Exp. Cell Res. 234:1997;285-292.
353. Maguire M.P., Sheets K.R., McVety K., Spada A.P., Zilberstein A. A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. J. Med. Chem. 37:1994;2129-2137.
354. Dolle R.E., Dunn J.A., Bobko M., Singh B., Kuster J.E., Baizman E., Harris A.L., Sawutz D.G., Miller D., Wang S., Faltynek C.R., Xie W., Sarup J., Bode D.C., Pagani E.D., Silver P.J. 5,7-Dimethoxy-3-(4-pyridinyl)quinoline is a potent and selective inhibitor of human vascular β-type platelet-derived growth factor receptor tyrosine kinase. J. Med. Chem. 37:1994;2627-2629.
355. Shawver L.K., Schwartz D.P., Mann E., Chen H., Tsai J., Chu L., Taylorson L., Longhi M., Meredith S., Germain L., Jacobs J.S., Tang C., Ullrich A., Berens M.E., Hersh E., McMahon G., Hirth K.P., Powell T.J. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl] 5-methylisoxazole-4-carboxamide. Clin. Cancer Res. 3:1997;1167-1177.
356. McGuire T.F., Qian Y.M., Vogt A., Hamilton A.D., Sebti S.M. Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation. J. Biol. Chem. 271:1996;27402-27407.
357. Domin J., Higgins T., Rozengurt E. Preferential inhibition of platelet-derived growth factor-stimulated DNA synthesis and protein tyrosine phosphorylation by nordihydroguaiaretic acid. J. Biol. Chem. 269:1994;8260-8267.
358. Mercola M., Deininger P.L., Shamah S.M., Porter J., Wang C.Y., Stiles C.D. Dominant-negative mutants of a platelet-derived growth factor gene. Genes Dev. 4:1990;2333-2341.
359. Vassbotn F.S., Andersson M., Westermark B., Heldin C.-H., Östman A. Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant. Mol. Cell. Biol. 13:1993;4066-4076.
360. Ueno H., Colbert H., Escobedo J.A., Williams L.T. Inhibition of PDGF β receptor signal transduction by coexpression of a truncated receptor. Science. 252:1991;844-848.
361. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
362. Sirois M.G., Simons M., Edelman E.R. Antisense oligonucleotide inhibition of PDGFR-β receptor subunit expression directs suppression of intimal thickening. Circulation. 95:1997;669-676.
363. S. Banai, Y. Wolf, G. Golomb, A. Pearle, J. Waltenberger, I. Fishbein, A. Schneider, A. Gazit, L. Perez, R. Huber, G. Lazarovichi, L. Rabinovich, A. Levitzki, S.D. Gertz, PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine, Circulation, in press.
364. Abboud H.E. Growth factors in glomerulonephritis. Kidney Int. 43:1993;252-267.
365. Johnson R.J., Raines E.W., Floege J., Yoshimura A., Pritzl P., Alpers C., Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J. Exp. Med. 175:1992;1413-1416.
366. Shamah S.M., Stiles C.D., Guha A. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol. Cell. Biol. 13:1993;7203-7212.
367. Strawn L.M., Mann E., Elliger S.S., Chu L.M., Germain L.L., Niederfellner G., Ullrich A., Shawver L.K. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-β receptor. J. Biol. 269:1994;21215-21222.
368. Vassbotn F.S., Östman A., Langeland N., Holmsen H., Westermark B., Heldin C.-H., Nistér M. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J. Cell. Physiol. 158:1994;381-389.
369. Liu Y.C., Chen S.C., Chang C.M., Leu C.M., Hu C.P. Platelet-derived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines. Exp. Cell Res. 228:1996;206-211.